The RE-UNITE-PN Study Design – A Prospective, Non-Interventional, Phase 4 Study of Nemolizumab for the Treatment of Prurigo Nodularis. J of Skin 2026, 10 (2), s767. https://doi.org/10.25251/q0ctfz86.